British Pregnancy Advisory Service

Last updated

The British Pregnancy Advisory Service (BPAS) is a British charity whose stated purpose is to avoid unwanted pregnancy by advocating and providing high quality, affordable services to prevent or end unwanted pregnancies with contraception or by abortion." [1]

Contents

Origin

BPAS was founded in 1968 in Birmingham as the Birmingham Pregnancy Advisory Service. On the day that the Abortion Act 1967 came into force, Saturday 27 April 1968, the first patients had their consultations in the front room of the then Chairman, Dr Martin Cole. [2] At that time, patients had to travel to London for termination, but a clinic was opened in Birmingham 18 months later. [2]

Abortion

In addition to providing abortion counselling and treatment at over 40 centres across England, Wales and Scotland (over 93% of clients have their abortion treatment funded by the NHS), [3] BPAS also provides emergency contraception, vasectomy and sterilisation, and vasectomy reversal services. BPAS's South London Clinic was one of the first recipients of the Department of Health 'You're Welcome' award in March 2009, for providing high standards of health care to young people.

BPAS gained substantial media attention in early 2011, when the charity went to the High Court seeking a legal re-definition of 'treatment' under the terms of the Abortion Act, which would have enabled women to have administered the second drug used in the 'abortion pill' treatment in their own homes. [4] BPAS argued that such a change would have brought UK practice into line with best clinical practice, and with practice in countries such as the USA, Sweden, and France; and that it would have dramatically improved the experience of early medical abortion for women. The judge in this case did not accept the definition of 'treatment' proposed by BPAS, but confirmed that the Secretary of State for Health has the power to approve women's homes as a 'class of place' where certain abortion drugs could be taken. [5]

In 2008 BPAS, along with other organisations in the Voice for Choice network, called for improvements to the abortion law during the Parliamentary debate over the Human Fertilisation and Embryology (HFE) Bill. The government guillotined discussion of the HFE Bill in such a way that proposed clauses related to abortion could not be debated. [6]

Donor insemination

From the early 1980s BPAS carried out donor insemination initially using fresh sperm which was produced by donors at the required time of the insemination. Sperm donation treatments provided by BPAS were anonymous and the identity of donors was protected. In the mid-1980s, following concerns about HIV, sperm which had been frozen and thawed by BPAS was used instead of fresh sperm. This enabled it to be quarantined and the donors re-tested. BPAS was known to be a clinic which would provide donor insemination to lesbians. [7]

BPAS continued to store donor sperm and to carry out treatments until the Human Fertilisation and Embryology Authority (HFEA) came into being in 1993.

Although it never carried out treatments under the Human Fertilisation and Embryology Act, the BPAS held a storage licence until the end of 1997.

In central London, the Pregnancy Advisory Service (PAS), also carried out treatments using donor sperm (vaginal inseminations in which the donor's semen is deposited at the entrance to the cervix, technically known as intracervical insemination) before the passing of the Act. Established primarily to facilitate abortions after 1968 with a clinic in Rosslyn Road, Twickenham and premises in Fitzroy Square, London, this organisation operated a donor insemination service from its premises in Charlotte Street, London W1. PAS held a treatment licence under the Act establishing the HFEA and continued to carry out artificial inseminations under its auspices. Unusually at the time, PAS operated a 'non-discrimination policy' which resulted in most of the patients of the PAS Donor Insemination Service being women without a male partner i.e. single women or coupled lesbians.

PAS never achieved high pregnancy rates with its donor insemination service, its average pregnancy rate being less than 8%. With a few donors it did reach rates of nearly 13% but with most donors the rate was considerably less. The reason for these low success rates was largely due to the method of fertilisation used.

PAS ceased to carry out donor insemination treatments at the end of 1996 when it risked insolvency and merged with the BPAS. The clinic at Charlotte Street continued to collect and process sperm samples from donors until October 1997. The BPAS sold the client list of PAS to the London Women's Clinic (LWC) in 1997. This comprised the names of mainly coupled lesbians and single women and from that date the LWC adopted an open policy for 'choice mothers' (women without a male partner). From January 1998 for a short time the LWC operated a donor insemination clinic known as the 'Charlotte Unit'. With the consent of the donors and in compliance with general directions issued by HFEA which covered such cases at the time, the BPAS sold its remaining stored donor sperm and that of PAS to fertility clinics outside the UK for use in donor treatments.

Criticism

In late 2004, the British newspaper The Daily Telegraph presented a video to the British government (Health Secretary Dr John Reid and Chief Medical Officer Professor Sir Liam Donaldson) showing BPAS counsellors referring women whose pregnancies were too advanced for legal abortions in Britain (past 24 weeks) to a clinic in Barcelona, Spain. [8] A report filed by the Chief Medical Officer for England, Professor Sir Liam Donaldson, in September, 2005 was critical of some aspects of BPAS counselling, but concluded that, in the matter of BPAS staff referring (in the broad sense, not the strict medical definition) women with late-term pregnancies to the Ginemedex clinic, BPAS had not broken any laws. The report stated unequivocally that BPAS's ability to provide abortion and reproductive counselling and services (within its mandate) had not in any way been compromised, and that no changes in funding should result. It further stated however, that protocol for late-term abortion counselling was sorely lacking, and that the government and interested agencies must develop said protocol with all possible speed. [9]

See also

Related Research Articles

<span class="mw-page-title-main">In vitro fertilisation</span> Assisted reproductive technology procedure

In vitro fertilisation (IVF) is a process of fertilisation where an egg is combined with sperm in vitro. The process involves monitoring and stimulating an individual's ovulatory process, removing an ovum or ova from their ovaries and letting sperm fertilise them in a culture medium in a laboratory. After the fertilised egg (zygote) undergoes embryo culture for 2–6 days, it is transferred by catheter into the uterus, with the intention of establishing a successful pregnancy.

<span class="mw-page-title-main">Artificial insemination</span> Pregnancy through in vivo fertilization

Artificial insemination is the deliberate introduction of sperm into a female's cervix or uterine cavity for the purpose of achieving a pregnancy through in vivo fertilization by means other than sexual intercourse. It is a fertility treatment for humans, and is common practice in animal breeding, including dairy cattle and pigs.

<span class="mw-page-title-main">Human Fertilisation and Embryology Authority</span>

The Human Fertilisation and Embryology Authority (HFEA) is an executive non-departmental public body of the Department of Health and Social Care in the United Kingdom. It is a statutory body that regulates and inspects all clinics in the United Kingdom providing in vitro fertilisation (IVF), artificial insemination and the storage of human eggs, sperm or embryos. It also regulates human embryo research.

<span class="mw-page-title-main">Assisted reproductive technology</span> Methods to achieve pregnancy by artificial or partially artificial means

Assisted reproductive technology (ART) includes medical procedures used primarily to address infertility. This subject involves procedures such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos, and/or the use of fertility medication. When used to address infertility, ART may also be referred to as fertility treatment. ART mainly belongs to the field of reproductive endocrinology and infertility. Some forms of ART may be used with regard to fertile couples for genetic purpose. ART may also be used in surrogacy arrangements, although not all surrogacy arrangements involve ART. The existence of sterility will not always require ART to be the first option to consider, as there are occasions when its cause is a mild disorder that can be solved with more conventional treatments or with behaviors based on promoting health and reproductive habits.

<span class="mw-page-title-main">Carl Wood</span>

Edwin Carlyle "Carl" Wood,, FRANZCOG was a prominent Australian gynaecologist, best known for his pioneering work developing and commercialising the technique of in-vitro fertilisation (IVF). He gained considerable international and national attention for his wide-ranging contributions in the field of women's health over a period of almost 50 years, although not all of it was positive given the controversial nature of many of his endeavours.

<span class="mw-page-title-main">Sperm bank</span> Facility that purchases, stores and sells human semen

A sperm bank, semen bank, or cryobank is a facility or enterprise which purchases, stores and sells human semen. The semen is produced and sold by men who are known as sperm donors. The sperm is purchased by or for other persons for the purpose of achieving a pregnancy or pregnancies other than by a sexual partner. Sperm sold by a sperm donor is known as donor sperm.

Ann Marie Furedi is the former chief executive of the British Pregnancy Advisory Service, the UK's largest independent abortion provider.

Jane Denton,, is a United Kingdom nurse and midwife notable for her contributions to fertility nursing and genetics. She was made a Fellow of the Royal College of Nursing in 2006.

<span class="mw-page-title-main">Reproductive medicine</span> Gynaecology

Reproductive medicine is a branch of medicine concerning the male and female reproductive systems. It encompasses a variety of reproductive conditions, their prevention and assessment, as well as their subsequent treatment and prognosis.

<span class="mw-page-title-main">Human Fertilisation and Embryology Act 1990</span> United Kingdom legislation

The Human Fertilisation and Embryology Act 1990 is an Act of the Parliament of the United Kingdom. It created the Human Fertilisation and Embryology Authority which is in charge of human embryo research, along with monitoring and licensing fertility clinics in the United Kingdom.

Posthumous sperm retrieval (PSR) is a procedure in which spermatozoa are collected from the testes of a human corpse after brain death. There has been significant debate over the ethics and legality of the procedure, and on the legal rights of the child and surviving parent if the gametes are used for impregnation.

Donor registration facilitates donor conceived people, sperm donors and egg donors to establish contact with genetic kindred. Registries are mostly used by donor conceived people to find out their genetic heritage and to find half-siblings from the same egg or sperm donor. In some jurisdictions donor registration is compulsory, while in others it is voluntary; but most jurisdictions do not have any registration system.

Sperm donation laws vary by country. Most countries have laws to cover sperm donations which, for example, place limits on how many children a sperm donor may give rise to, or which limit or prohibit the use of donor semen after the donor has died, or payment to sperm donors. Other laws may restrict use of donor sperm for in vitro fertilisation (IVF) treatment, which may itself be banned or restricted in some way, such as to married heterosexual couples, banning such treatment to single women or lesbian couples. Donated sperm may be used for insemination or as part of IVF treatment. Notwithstanding such laws, informal and private sperm donations take place, which are largely unregulated.

Fertility tourism is the practice of traveling to another country or jurisdiction for fertility treatment, and may be regarded as a form of medical tourism. One can usually be considered as having fertility issues when they are unable to have a clinical pregnancy after 12 months of attempts with intercourse. Infertility, or the inability to get pregnant, affects about 8-12% of couples looking to conceive or 186 million people globally. In some places, rates of infertility surpass the global average and can go up to 30% depending on the country. Areas with lack of resources, such as assisted reproductive technologies (ARTs), tend to correlate with the highest rates of infertility.

Sperm donation is the provision by a man of his sperm with the intention that it be used in the artificial insemination or other 'fertility treatment' of a woman or women who are not his sexual partners in order that they may become pregnant by him. Where pregnancies go to full term, the sperm donor will be the biological father of every baby born from his donations.

The following outline is provided as an overview of and topical guide to obstetrics:

<span class="mw-page-title-main">Human Fertilisation and Embryology Act 2008</span> United Kingdom legislation

The Human Fertilisation and Embryology Act 2008 is an Act of the Parliament of the United Kingdom. The Act constitutes a major review and update of the Human Fertilisation and Embryology Act 1990.

Mitochondrial replacement therapy (MRT), sometimes called mitochondrial donation, is the replacement of mitochondria in one or more cells to prevent or ameliorate disease. MRT originated as a special form of in vitro fertilisation in which some or all of the future baby's mitochondrial DNA (mtDNA) comes from a third party. This technique is used in cases when mothers carry genes for mitochondrial diseases. The therapy is approved for use in the United Kingdom. A second application is to use autologous mitochondria to replace mitochondria in damaged tissue to restore the tissue to a functional state. This has been used in clinical research in the United States to treat cardiac-compromised newborns.

Mary Barton was a British obstetrician who, in the 1930s, founded one of the first fertility clinics in England to offer donor insemination. Throughout her career, Barton studied infertility and conception. Her pioneering research and practice were inspired by experience as a medical missionary in India, where she saw the harsh treatment of childless women.

<span class="mw-page-title-main">London Women's Clinic</span>

The London Women's Clinic is a private healthcare centre situated in London's Harley Street. Owned by Dr Kamal Ahuja, and founded in 1992, the centre has a reputation for helping single women and lesbian couples conceive with a total of over 85% of patients at its London clinic being in one of these categories.The clinic is closely associated with the London Sperm Bank and the London Egg Bank.

References

  1. ↑ BPAS homepage - About BPAS
  2. 1 2 Calthorpe Clinic Medical Seminar 26 September 2007 [ permanent dead link ].
  3. ↑ "Our Services". Archived from the original on 3 November 2011. Retrieved 13 June 2011.
  4. ↑ "Early medical abortions: bid to change the law". BBC News. 13 January 2011. Retrieved 3 October 2021.
  5. ↑ "Press Releases". 28 September 2011. Archived from the original on 28 September 2011. Retrieved 3 October 2021.
  6. ↑ "FPA and the Human Fertilisation and Embryology (HFE) Bill debate - Activity in Westminster - FPA". 23 July 2011. Archived from the original on 23 July 2011. Retrieved 3 October 2021.
  7. ↑ https://edm.parliament.uk/early-day-motion/3034/british-pregnancy-advisory-service-and-virgin-births [ bare URL ]
  8. ↑ Edwardes, Charlotte; Foggo, Daniel (21 November 2004). "British doctor admits arranging abortions in eighth month". The Daily Telegraph .
  9. ↑ "An investigation into the British Pregnancy Advisory Service response to requests for late abortions: A report by the Chief Medical Officer". UK Department of Health . 21 September 2005. Retrieved 22 July 2017.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.